New York City
Minimum $50,000 per annum + Benefits (Salary Commensurate with experience)
January 09 2019
Position Type
Full Time
Organization Type
Job Type

Postdoctoral position available to study cytolytic T cell- and chemoradiation-stimulated tumor cell death upon signal transduction via the second messenger ceramide. Cell death signaling focuses on the role of ischemia-reperfusion injury induced SUMOylation defects in the context of homologous recombination misrepair. Proprietary small molecule and gene therapy vectors under clinical development represent a major strength of this program. Strong clinical teams in place as collaborators for coordinated clinical translation at Memorial Sloan Kettering Cancer Center. Interested candidates please send curriculum vitae to:

Richard Kolesnick

Professor of Molecular Pharmacology, Weill Cornell Medical College

Member, Sloan Kettering Institute

Similar jobs

Similar jobs